CN210674013U - Multi-mode analgesia equipment - Google Patents
Multi-mode analgesia equipment Download PDFInfo
- Publication number
- CN210674013U CN210674013U CN201921064294.9U CN201921064294U CN210674013U CN 210674013 U CN210674013 U CN 210674013U CN 201921064294 U CN201921064294 U CN 201921064294U CN 210674013 U CN210674013 U CN 210674013U
- Authority
- CN
- China
- Prior art keywords
- main control
- control chip
- unit
- micro
- taes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Abstract
The application discloses multi-mode analgesia equipment, including main control chip, percutaneous acupuncture point electro photoluminescence TAES unit, micro-injection pump, power control unit and human-computer interaction unit: the human-computer interaction unit is connected to the main control chip and used for outputting a user operation instruction to the main control chip and displaying output data of the main control chip; the TAES unit is connected to the main control chip and used for generating and outputting the pulse electrical stimulation wave under the control of the main control chip; the micro drug injection pump is connected to the main control chip and is used for drug pump injection under the control of the main control chip; the power supply control unit is respectively connected with the main control chip, the TAES unit and the micro-injection pump and is used for switching on or off the power supply of the TAES unit and switching on or off the power supply of the micro-injection pump under the control of the main control chip. The application realizes that the dosage of the analgesic drug is reduced under the condition of achieving the same analgesic effect.
Description
Technical Field
The utility model relates to the technical field of medical appliances, more specifically say, relate to a multi-mode analgesia equipment.
Background
Pain is the fifth vital sign of the human body. Certain types of pain, such as intractable chronic pain, post-operative pain, cancer pain, etc., which cannot be effectively alleviated, can adversely affect the patient both physiologically and psychologically.
The drug therapy is the most commonly adopted analgesic mode, and the clinical commonly used analgesic drugs comprise antidepressant drugs, anticonvulsant drugs, opioid drugs and the like, but the analgesic drugs have obvious side effects after being applied in large quantities for a long time, such as causing confusion, incapability of eating, constipation, vomiting and the like.
Therefore, how to reduce the dosage of analgesic drugs under the condition of achieving the same analgesic effect is an urgent problem to be solved in the field.
SUMMERY OF THE UTILITY MODEL
In view of this, the utility model provides a multi-mode analgesia equipment to realize reaching under the condition of same analgesia effect, reducing the quantity of analgesia medicine.
A multi-mode analgesia device comprises a main control chip, a percutaneous acupoint electrostimulation TAES unit, a micro-injection pump, a power supply control unit and a man-machine interaction unit, wherein:
the human-computer interaction unit is connected to the main control chip and used for outputting a user operation instruction to the main control chip and displaying output data of the main control chip;
the TAES unit is connected to the main control chip and used for generating and outputting pulse electrical stimulation waves under the control of the main control chip;
the micro drug injection pump is connected to the main control chip and is used for drug pumping under the control of the main control chip;
the power supply control unit is respectively connected with the main control chip, the TAES unit and the micro-injection pump and is used for switching on or off the power supply of the TAES unit and switching on or off the power supply of the micro-injection pump under the control of the main control chip.
Optionally, the multi-mode analgesia device further comprises: and the pain information comprehensive dynamic evaluation device is connected with the main control chip and is used for measuring the pain information parameters of the human body under the control of the main control chip.
Optionally, the pain information comprehensive dynamic evaluation device comprises one or more of a heart rate variability parameter measuring device and a pain vision simulation evaluation device.
Optionally, the TAES unit includes an electric pulse generating device and an electric pulse acting device, wherein:
the electric pulse generating device is used for generating required pulse electric stimulation waves under the control of the main control chip;
the electric pulse action device is used for receiving the pulse electric stimulation waves and leading the pulse electric stimulation waves out to the electrode piece connected with the tail end of the electrode wire through the electrode wire.
Optionally, the micro-injection pump comprises a drug storage box, a driving and executing mechanism and a liquid medicine output pipe, wherein:
the driving and executing mechanism is used for pumping the medicine in the medicine storage box into the body of the patient through the liquid medicine output pipe under the control of the main control chip.
Optionally, the micro-injection pump further includes a medication monitoring device, configured to report to the main control chip when an abnormal condition occurs during the process of pumping the medication by the micro-injection pump.
Optionally, the power control unit includes a first controllable switch and a second controllable switch, wherein:
the first controllable switch is connected in series with a power supply line of the TAES unit;
the first controllable switch is connected in series with a power supply line of the micro-injection pump;
and the control ends of the first controllable switch and the second controllable switch are connected to the main control chip.
Optionally, the human-computer interaction unit is a local operation panel with a display and a keyboard.
Optionally, the human-computer interaction unit is a remote controller with a display and a keyboard.
Optionally, the multi-mode analgesia device further comprises: and the buzzer is connected with the main control chip.
According to the above technical scheme, the utility model discloses assembled TAES unit and trace injection pump simultaneously in multi-mode analgesia equipment, multi-mode analgesia equipment just has TAES and two kinds of analgesia modes of drug analgesia concurrently like this, and both cooperate and use, can reduce the quantity of analgesia medicine under the condition that reaches same analgesia effect.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without creative efforts.
Fig. 1 is a schematic structural view of a multi-mode analgesic device disclosed in the embodiment of the present invention;
fig. 2 is a schematic structural view of another multi-mode analgesic device disclosed in the embodiment of the present invention;
fig. 3 is a schematic structural diagram of a TAES unit disclosed in an embodiment of the present invention;
fig. 4 is a schematic structural view of a micro-injection pump disclosed in an embodiment of the present invention;
fig. 5 is a schematic structural view of another micro-injection pump disclosed in the embodiment of the present invention;
fig. 6 is a schematic structural diagram of a power control unit according to an embodiment of the present invention;
fig. 7 is a schematic structural view of another multi-mode analgesic device disclosed in the embodiment of the present invention;
fig. 8 is a schematic view of the multi-mode analgesic device according to the embodiment of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the accompanying drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative work belong to the protection scope of the present invention.
As shown in fig. 1, the embodiment of the present invention discloses a multi-mode analgesia device, comprising a main control chip 100, a TAES (percutaneous Electrical stimulation) unit 200, a micro-injection pump 300, a power control unit 400 and a human-computer interaction unit 500, wherein:
the human-computer interaction unit 400 is connected to the main control chip 100, and is configured to output a user operation instruction to the main control chip 100 and display output data of the main control chip 100;
the TAES unit 200 is connected to the main control chip 100, and is configured to generate and output a pulsed electrical stimulus wave under the control of the main control chip 100;
the micro drug injection pump 300 is connected to the main control chip 100 and is used for drug pumping under the control of the main control chip 100;
the power control unit 400 is respectively connected to the main control chip 100, the TAES unit 200 and the micro-injection pump 300, and is configured to switch on or off the power supply of the TAES unit 200 and switch on or off the power supply of the micro-injection pump 300 under the control of the main control chip 100.
The working principle of the multimode analgesic device shown in fig. 1 is as follows:
acupuncture analgesia is one of the most marked results in the field of acupuncture research in traditional Chinese medicine, and TAES (TAES fatty acid ester synthase) is proved to have the same analgesic effect as acupuncture in the prior art. Therefore, the TAES unit 200 is assembled in the multi-mode analgesia device in the embodiment, and during treatment, the TAES unit 200 can be started to electrically stimulate specific acupuncture points of a human body, so that morphine substances such as endorphins, enkephalins, dynorphins and the like with analgesia functions in the nervous system of the human body are released, and the analgesia effect same as that of acupuncture is generated.
However, considering the problem of insufficient analgesia due to the simple use of TAES, the multi-mode analgesia device of the present embodiment is further equipped with a micro-infusion pump 300, and during treatment, the TAES unit 200 may be activated simultaneously with the micro-infusion pump 300 to infuse the analgesia pump into the patient, or the TAES unit 200 and the micro-infusion pump 300 may be alternately activated. Therefore, the multimode analgesia equipment has two analgesia modes of TAES and drug analgesia, and the two analgesia modes are matched for use, so that the dosage of the analgesia drug can be reduced under the condition of achieving the same analgesia effect.
The on/off state switching of the TAES unit 200 is realized by the control chip 100 controlling the power control unit 400 to switch on/off the power supply of the TAES unit 200; the on/off state switching of the micro-injection pump 300 is realized by the control chip 100 controlling the power control unit 400 to switch on/off the power supply of the micro-injection pump 300; the operating parameters of the TAES unit 200 (e.g., the parameters related to the generation of the type of the pulsed electrical stimulation) and the operating parameters of the micro-drug pump 300 (e.g., the parameters related to the flow rate at which the drug is pumped) are determined by the control chip 100. In summary, the control chip 100 is the "brain" of the multi-mode analgesic device, and is responsible for orderly working of each component in the multi-mode analgesic device, the user performs information interaction with the control chip 100 through the human-computer interaction unit 500, and the control chip 100 controls the corresponding component in the multi-mode analgesic device according to the operation instruction of the user, and feeds back the control result to the human-computer interaction unit 500 to be displayed to the user.
The power supply of the TAES unit 200 may be, for example, an external 220V 50Hz adapter. The power supply of the micro-syringe pump 300 may be, for example, a 9V dry cell battery.
The human-computer interaction unit 500 may be a local operation panel with a display and a keyboard, or may be a remote controller with a display and a keyboard, but is not limited thereto.
Optionally, as shown in fig. 2, the above multimode analgesic device further comprises: the pain information comprehensive dynamic evaluation device 600 is connected to the main control chip 100 and is used for measuring pain information parameters of the human body under the control of the main control chip 100.
The pain information comprehensive dynamic evaluation device 600 may be composed of one or more of a heart rate variability parameter measuring device and a VAS (visual analog Scale, pain visual analog score) device, for example, and is configured to perform comprehensive dynamic evaluation and feedback on pain information based on the change of parameters such as the heart rate variability and the VAS of a human body under the control of the main control chip 100, and the measurement result is fed back to the human-computer interaction unit 500 for displaying, so as to guide the clinical application of the multi-mode analgesic device. Moreover, the patient's heart rate variability parameters, VAS, etc. can be used by the main control chip 100 to determine whether to autonomously adjust the operating parameters and start/stop times of the TAES unit 200 and the micro-infusion pump 300.
In any of the multimode analgesic devices disclosed above, the specific structure of the TAES unit 200 is shown in fig. 3, and includes an electric pulse generating device 201 and an electric pulse acting device 202, wherein:
the electric pulse generating device 201 is used for generating a required pulse electric stimulation wave under the control of the main control chip 100;
the electric pulse action device 202 is used for receiving the pulse electrical stimulation waves and leading the pulse electrical stimulation waves out to an electrode sheet connected with the tail end of the electrode wire through the electrode wire; the electric pulse action device 202 may include one or more electrode wires, each electrode wire having at least one electrode pad attached thereto. For example, the electric pulse action device 202 includes one electrode wire to which 4 electrode pads are connected.
Specifically, during treatment, the electrode plates in the electric pulse action device 202 are respectively attached to different acupuncture points of a human body, the main control chip 100 controls the electric pulse generation device 201 to generate pulse electric stimulation waves with preset frequency, intensity and duty ratio, the pulse electric stimulation waves are transmitted to the electrode plates through electrode wires, and meanwhile, the acupuncture points of the human body are electrically stimulated, so that morphine substances such as endorphin, enkephalin, dynorphin and the like with an analgesic function in a nervous system of the human body are released, and the analgesic effect same as that of acupuncture is generated.
Optionally, the main control chip 100 controls the electric pulse generating device 201 to perform constant current output, so as to ensure that the output current does not change due to the difference of skin positions.
Optionally, in the frequency setting of the pulsed electrical stimulation, the main control chip 100 may control the electrical pulse generating device 201 to generate a sparse wave constant amplitude wave (for example, an intermittent 2Hz electrical pulse, a 5Hz electrical pulse, or a 10Hz electrical pulse), or the main control chip 100 can control the electric pulse generator 201 to generate a dense wave with a constant amplitude (for example, an intermittent 15Hz electric pulse, a 30Hz electric pulse, a 50Hz electric pulse or a 100Hz electric pulse), or the main control chip 100 can control the electric pulse generating device 201 to generate density and density constant amplitude waves (for example, 2Hz/100HZ alternating electric pulses, 2Hz/50Hz alternating electric pulses, 2Hz/30Hz alternating electric pulses or 2Hz/15Hz alternating electric pulses), alternatively, the main control chip 100 may control the electric pulse generator 201 to generate AM amplitude modulated waves (e.g., AM15Hz electric pulse, AM30Hz electric pulse, AM50Hz electric pulse, or AM100Hz electric pulse). In the embodiment, after default starting, 2Hz/100HZ alternating electric pulses are adopted, and as the wave width of the electric pulses changes along with the frequency, the wave width is narrowed when the frequency is increased, so that a typical TENS-like waveform is formed; when the frequency is reduced, the wave width is widened to become a typical acupuncture-like stimulation waveform, and when the electric pulse with the frequency of 2Hz/100HZ alternation is adopted, the embodiment can have the advantages of TENS and acupuncture.
Optionally, in the setting of the intensity of the pulse electrical stimulation wave, the main control chip 100 may control the electrical pulse generating device 201 to output an electrical pulse of 0 to 50mA, for example, and the parameter control is accurate to 1 mA. In addition, in the present embodiment, it is recommended that the main control chip 100 controls the electric pulse generating device 201 to output symmetrical bidirectional pulse waves, so as to ensure that the stimulation amounts of the electrode pads are completely the same.
Optionally, in the setting of the duty ratio of the pulsed electrical stimulation wave, the main control chip 100 may control the electrical pulse generating device 201 to output an electrical pulse of 0.2 to 0.6 milliseconds, for example.
Optionally, the main control chip 100 can control the electric pulse generating device 201 to default treatment time after each power-on, for example, there are 5 choices, such as 15 minutes, 30 minutes, 45 minutes, 60 minutes, and unlimited time.
In any of the multimode analgesic devices disclosed above, the micro-infusion pump 300 has a specific structure as shown in fig. 4, and includes a drug reservoir 301, a driving and actuating mechanism 302, and a drug solution delivery tube 303.
The driving and executing mechanism 302 pumps the medicine in the medicine storage box 301 into the patient through the medicine liquid output tube 303 under the control of the main control chip 100. The volume of the drug reservoir 301 may be selected from, but is not limited to, 100 ml to 300 ml.
Because of the computer control, the micro-injection pump 300 can accurately output the medicine in a timing and quantitative manner, and realize the uniform output of the medicine in a micro-amount manner.
Optionally, in any of the above-disclosed multimode analgesic devices, as shown in fig. 5, the micro-syringe pump 300 further includes a medication monitoring device 304, configured to report the main control chip 100 when an abnormal condition (for example, the infusion in the drug storage box 301 is over, or the blockage, air bubble, etc. in the drug output tube 303 occurs) is detected during the drug pumping process of the micro-syringe pump 300. Then, the main control chip 100 can control the human-computer interaction unit 200 to display corresponding alarm words, so that the medical personnel can find problems in time and can perform corresponding treatment in time.
In any of the multimode analgesic devices disclosed above, the specific structure of the power supply control unit 400 is shown in fig. 6, and comprises a first controllable switch K1 and a second controllable switch K2, wherein:
the first controllable switch K1 is connected in series with the power supply line of the TAES cell 200, the first controllable switch K1 is connected in series with the power supply line of the micro-injection pump 300, and the control terminals of the first controllable switch K1 and the second controllable switch K2 are both connected to the main control chip 100.
Optionally, as shown in fig. 7, any of the above-disclosed multi-mode analgesia devices further comprises a buzzer 700, wherein the buzzer 700 is connected with the main control chip 100 and is used for sending out an alarm signal under the control of the main control chip 100 so as to avoid delayed processing caused by the fact that the patient and the medical care personnel cannot find the alarm words displayed by the man-machine interaction unit 200 in time.
Any of the above disclosed multimodal analgesia devices is designed to be portable, following the principles of compact, highly integrated design. The overall dimensions are, for example, 306mm long, 370mm wide and 120mm high. Fig. 7 shows a schematic external form of the multi-mode analgesic device, and fig. 8 shows only one electrode wire 2021 to which 4 electrode pads 2022 are connected, wherein the electric pulse applying means 202 is provided.
To sum up, the utility model discloses a multi-mode analgesia equipment of adoption chinese and western medicine combination principle is applicable to the analgesia and the treatment of various acute and chronic painful diseases, for example operation analgesia, postoperative analgesia, childbirth analgesia, various intractable chronic painful diseases (for example various headache, neck shoulder low back pain, arthralgia, cancer pain, postherpetic pain, dysmenorrheal etc.), also can be applicable to the rehabilitation physiotherapy of withdrawal from addiction treatment (for example poison, wine, net, gambling, cigarette), children's autism, apoplexy paralysis etc.. The equipment organically combines TAES and drug analgesia together, and can obviously reduce the dosage of various analgesic drugs under the condition of achieving the same analgesia effect, thereby reducing adverse reactions caused by the large-scale application of various analgesic drugs.
The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. The multi-mode analgesia equipment is characterized by comprising a main control chip, a percutaneous acupoint electrostimulation TAES unit, a micro-injection pump, a power supply control unit and a man-machine interaction unit, wherein:
the human-computer interaction unit is connected to the main control chip and used for outputting a user operation instruction to the main control chip and displaying output data of the main control chip;
the TAES unit is connected to the main control chip and used for generating and outputting pulse electrical stimulation waves under the control of the main control chip;
the micro drug injection pump is connected to the main control chip and is used for drug pumping under the control of the main control chip;
the power supply control unit is respectively connected with the main control chip, the TAES unit and the micro-injection pump and is used for switching on or off the power supply of the TAES unit and switching on or off the power supply of the micro-injection pump under the control of the main control chip.
2. The multi-mode analgesic device of claim 1, further comprising: and the pain information comprehensive dynamic evaluation device is connected with the main control chip 100 and is used for measuring the pain information parameters of the human body under the control of the main control chip 100.
3. The multimodal analgesia apparatus of claim 2 wherein the pain information integrated dynamics assessment device comprises one or more of a heart rate variability parameter measurement device and a pain vision simulation assessment device.
4. The multimodal analgesia apparatus of claim 1, 2 or 3 wherein the TAES cell comprises electrical pulse generating means and electrical pulse application means, wherein:
the electric pulse generating device is used for generating required pulse electric stimulation waves under the control of the main control chip;
the electric pulse action device is used for receiving the pulse electric stimulation waves and leading the pulse electric stimulation waves out to the electrode piece connected with the tail end of the electrode wire through the electrode wire.
5. The multimodal analgesia device of claim 1, 2 or 3 wherein the microinjection pump comprises a drug reservoir, a drive and actuator, and a drug solution delivery tube, wherein:
the driving and executing mechanism is used for pumping the medicine in the medicine storage box into the body of the patient through the liquid medicine output pipe under the control of the main control chip.
6. The multi-mode analgesic device of claim 5 wherein the micro-infusion pump further comprises a medication monitoring device for reporting to the main control chip when an abnormal condition is monitored during the process of the micro-infusion pump for medication pumping.
7. The multimode analgesic device of claim 1, 2 or 3 wherein the power control unit comprises a first controllable switch and a second controllable switch, wherein:
the first controllable switch is connected in series with a power supply line of the TAES unit;
the first controllable switch is connected in series with a power supply line of the micro-injection pump;
and the control ends of the first controllable switch and the second controllable switch are connected to the main control chip.
8. A multimodal analgesia device according to claim 1, 2 or 3 wherein the human interaction unit is a local operating panel with a display and a keyboard.
9. A multimodal analgesia device according to claim 1, 2 or 3 wherein the human interaction unit is a remote control with a display and a keyboard.
10. The multimode analgesic device of claim 1, 2, or 3 further comprising: and the buzzer is connected with the main control chip.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921064294.9U CN210674013U (en) | 2019-07-09 | 2019-07-09 | Multi-mode analgesia equipment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921064294.9U CN210674013U (en) | 2019-07-09 | 2019-07-09 | Multi-mode analgesia equipment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN210674013U true CN210674013U (en) | 2020-06-05 |
Family
ID=70890308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201921064294.9U Active CN210674013U (en) | 2019-07-09 | 2019-07-09 | Multi-mode analgesia equipment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN210674013U (en) |
-
2019
- 2019-07-09 CN CN201921064294.9U patent/CN210674013U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9333346B1 (en) | Multi-mode microcurrent stimulus system with safety circuitry and related methods | |
| US10849822B2 (en) | Control method and control device for cessation of vomiting | |
| US20120259390A1 (en) | Wearable Photvoltaic Ultra-Low frequency Acupoint Stimulator | |
| CN204543277U (en) | Biofeedback therapy Apparatus and system | |
| CN103212157B (en) | Bipolar general nerve electric stimulation instrument | |
| CN111671645A (en) | Limb pain treatment pen utilizing physical kinetic energy and therapeutic apparatus applying same | |
| CN210674013U (en) | Multi-mode analgesia equipment | |
| CN107427680A (en) | Vein electrical stimulation device and its method and application | |
| US20060111756A1 (en) | Method and apparatus for a neuromuscular stimulator | |
| CN203280903U (en) | Transcutaneous vagus nerve stimulation system | |
| CN101052440B (en) | Stimulating apparatus for preventing non-breathing state | |
| CN208017769U (en) | A kind of multifunctional moxibustion instrument | |
| KR20050102615A (en) | Low frequency, supersonic waves, color therapy all style probe | |
| CN105611964A (en) | Venous electrical stimulation apparatus and methods | |
| CN205460472U (en) | Traditional chinese medical science transdermal electrotherapy circuit | |
| CN100998908A (en) | Bipath ear point therapeutic instrument for eye brain disease based on placenta signal generating technology | |
| CN204637305U (en) | Diabetes detect and physical therapeutic system | |
| CN204469017U (en) | Diabetes detect and physical therapy device | |
| CN200991510Y (en) | Modulation-type supersonic frequency field energy multi-purpose treatment instrument | |
| CN201519385U (en) | Ultrasonic prostate therapeutic apparatus | |
| RU2325929C2 (en) | Method of electric impact on living organism and related device | |
| CN215875964U (en) | Intelligent electric acupuncture hypertension instrument | |
| CN2933289Y (en) | Myoelectric diagnostic treater | |
| CN105411663B (en) | The anti-breaking orthopedic steel plate of intelligence | |
| CN109045470A (en) | A kind of multi-functional Frequency Adjustable low pressure negative potential pulse physiotherapy instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |